AtriCure, Inc.
$58.10
-$1.02 (-1.73%)
$57.98Day Range$59.88
Key Statistics
Market Cap
$2.96B
Shares Outstanding
50.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 5, 2005
Round Lot
100
Locale
US
Trading Data
Day Open
$58.51
Day High
$59.88
Day Low
$57.98
Volume
8.67M
VWAP
$58.25
Prev Close
$59.12
Transactions
--
Acc. Volume
--
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 38411,350 employees7555 INNOVATION WAY, MASON, OH, 45040513-755-4100IPO Aug 5, 2005US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001323885
- Composite FIGI
- BBG000BL6CB5
- Share Class FIGI
- BBG001SD43V3
- Ticker Root
- ATRC
- SIC Code
- 3841
About AtriCure, Inc. (ATRC) Stock
AtriCure, Inc. (ATRC) closed the 2026-09-18 session at $58.10, down 1.73% versus the previous close (-1.02). The stock opened at $58.51 and traded between $57.98 and $59.88 during that session. Session trading volume was 8.7M shares. The volume-weighted average price (VWAP) is $58.25.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
AtriCure, Inc. has a market capitalization of $2.96 billion. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. ATRC is listed on the XNAS exchange. The company employs approximately 1,350 people. AtriCure, Inc. is headquartered in MASON, OH. The recorded listing date is 2005-08-05.
On this page you can find market ATRC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.